Pros and cons of shortening medical school discussed

Pros and cons of shortening medical school discussed
The pros and cons of shortening medical school to three years are discussed in two perspective pieces published in the Sept. 19 issue of the New England Journal of Medicine

(HealthDay)—The pros and cons of shortening medical school to three years are discussed in two perspective pieces published in the Sept. 19 issue of the New England Journal of Medicine.

Steven B. Abramson, M.D., from the New York University Langone Medical Center in New York City, and colleagues discuss the benefits of shortening to three years, citing the example of fast-track programs currently offered at some institutions. Benefits of shortened training include allowing graduates to enter practice sooner and increase the physician-years in practice, helping to address the physician shortage. In addition, the three-year pathway could reduce the student , by simultaneously reducing debt and also providing an additional year of earnings. Careful mentoring and monitoring is recommended for the success of a shortened training program.

Stanley Goldfarb, M.D., and Gail Morrison, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, discuss the potential shortcomings of shortening medical school. The authors note that, although exceptional may be capable of accelerated learning, for typical students, the duration of medical school should not be reduced. Past efforts to reduce the duration of medical school have been aborted; students and faculty felt pressured by the compression of the material. Students who completed medical school in three years reported feeling exhausted, and many extended their studies. Students should be better prepared for the transition to residency; the current fourth-year curriculum fails to prepare students for more advanced responsibilities and should focus on expanding clinical and non-.

"Given the growing complexity of medicine, it seems counterproductive to compress the curriculum into three years, reducing both preclinical and clinical experiences," Goldfarb and Morrison write.

More information: Full Text - Abramson
Full Text - Goldfarb and Morrison

add to favorites email to friend print save as pdf

Related Stories

Growing mismatch in med school graduates, GME places

Jun 25, 2013

(HealthDay)—Although the number of medical school enrollees and graduates is increasing, the number of U.S. graduate medical education (GME) programs has not increased at the same rate, and consequently ...

Online dermatology education effective among students

Aug 24, 2013

(HealthDay)—An online dermatology curriculum significantly improves dermatology knowledge among medical students taking an introductory dermatology clerkship, according to research published in the August ...

Enrollment in US medical colleges is increasing

May 29, 2013

(HealthDay)—Enrollment in U.S. medical colleges is increasing, but there is concern about the adequacy of training opportunities, according to a report published by the Association of American Medical Colleges ...

Recommended for you

Doctor behind 'free radical' aging theory dies

11 hours ago

Dr. Denham Harman, a renowned scientist who developed the most widely accepted theory on aging that's now used to study cancer, Alzheimer's disease and other illnesses, has died in Nebraska at age 98.

Mexican boy who had massive tumor recovering

21 hours ago

An 11-year-old Mexican boy who had pieces of a massive tumor removed and who drew international attention after U.S. officials helped him get treatment in the southwestern U.S. state of New Mexico is still recovering after ...

New medical device to make the mines safer

Nov 21, 2014

Dehydration can be a serious health issue for Australia's mining industry, but a new product to be developed with input from Flinders University's Medical Device Partnering Program (MDPP) is set to more effectively ...

US family gets $6.75 million in Botox case

Nov 20, 2014

A New York couple who said Botox treatment of their son's cerebral palsy left him with life-threatening complications and sued its manufacturer won a $6.75 million verdict from a federal jury on Thursday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.